HYPERION DEFI, INC. Payments of Debt Issuance Costs
HYPERION DEFI, INC. (HYPD) reported Payments of Debt Issuance Costs of $2.37 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2025-04-15
- HYPERION DEFI, INC. payments of debt issuance costs for the quarter ending 2024-12-31 was $470.71K.
- HYPERION DEFI, INC. payments of debt issuance costs for the quarter ending 2023-12-31 was $0.00.
- HYPERION DEFI, INC. payments of debt issuance costs for the quarter ending 2023-09-30 was $965.37K.
- HYPERION DEFI, INC. payments of debt issuance costs for the quarter ending 2020-09-30 was $650.21K.
- HYPERION DEFI, INC. payments of debt issuance costs for fiscal 2024 was $2.37M, a 117.50% increase from fiscal 2023.
- HYPERION DEFI, INC. payments of debt issuance costs for fiscal 2023 was $1.09M.
- HYPERION DEFI, INC. payments of debt issuance costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- HYPERION DEFI, INC. payments of debt issuance costs for fiscal 2021 was $66.62K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 9 month as first filed | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $470.71K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $2.37M 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $1.90M 10-Q · filed 2024-11-12 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $965.37K derived: sum of 2 quarters · filed 2025-04-15 | $1.09M 10-K · filed 2025-04-15 | ||
| 2023-09-30 | $965.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.09M 10-Q · filed 2024-11-12 | $125.98K 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $125.98K 10-Q · filed 2023-08-11 | ||||
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 | ||||
| 2021-12-31 | $66.62K 10-K · filed 2023-03-31 | ||||
| 2020-09-30 | $650.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $650.21K derived: sum of 2 quarters · filed 2021-11-12 | $1.07M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $415.80K 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | $415.80K 10-Q · filed 2020-05-14 | ||||
| 2019-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$1.40M derived: sum of 2 quarters · filed 2019-11-13 | $815.05K 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $2.21M 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | $2.21M 10-Q · filed 2019-05-14 | ||||
| 2018-09-30 | $2.21M 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |